North America Neuropathic Pain Market to 2032
Overview
The North America Neuropathic Pain Market is expected to reach a 6,828.36 USD Billion by 2032 and is projected to grow at a CAGR of 14.56% from 2025 to 2032.
Revenue, 2024 (USD Billion)
3,359.53
Forecast, 2032 (USD Billion)
6,828.36
CAGR, 2024 - 2032
14.56%
Report Coverage
North America
North America Neuropathic Pain Market 2018-2032 USD Billion
North America Neuropathic Pain Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3,359.53 USD Billion
- Projected Market Size (2032): 6,828.36 USD Billion
- CAGR (2025-2032): 14.56%
Key Findings of North America Neuropathic Pain Market
- The North America Neuropathic Pain Market was valued at 3,359.53 USD Billion in 2024.
- The North America Neuropathic Pain Market is likely to grow at a CAGR of 14.56% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Devices in Mode of Purchase Segment accounted for the largest share of the market with a revenue of 2,555.08 USD Billion
- The fastest growing segment Peripheral Neuropathy in Pain Type Segment grew Fastest with a CAGR of 15.86% during the forecast period from 2024 to 2032.
North America Neuropathic Pain Market Scope
North America Neuropathic Pain Market Segmentation & Scope
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
North America Neuropathic Pain Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3,359.53 USD Billion |
| Market Value in 2032 | 6,828.36 USD Billion |
| CAGR (2025-2032) | 14.56% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Pain Type,Indication,Type,Product Type,Procedure,Technology,Modality,Mode of Purchase |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 3,359.53 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 3,042.23 USD Billion in 2024.
Segments and Scope
-
North America Neuropathic Pain Market to 2032, By End User
- Clinics is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 1,048.82 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 15.62 % in forecast period 2025-2032.
-
North America Neuropathic Pain Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 2,213.82 USD Billion in the year 2024.
- Direct Tenders is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 14.87 % in forecast period 2025-2032.
-
North America Neuropathic Pain Market to 2032, By Pain Type
- Peripheral Neuropathy is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 738.27 USD Billion in the year 2024.
- Peripheral Neuropathy is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 15.86 % in forecast period 2025-2032.
-
North America Neuropathic Pain Market to 2032, By Indication
- Spinal Stenosis is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 1,390.96 USD Billion in the year 2024.
- Diabetic Neuropathy is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 14.38 % in forecast period 2025-2032.
-
North America Neuropathic Pain Market to 2032, By Type
- Spinal Cord Stimulation (SCS) Devices is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 2,049.56 USD Billion in the year 2024.
- Spinal Cord Stimulation (SCS) Devices is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 15.04 % in forecast period 2025-2032.
-
North America Neuropathic Pain Market to 2032, By Product Type
- Rechargeable is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 2,228.04 USD Billion in the year 2024.
- Rechargeable is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 15.08 % in forecast period 2025-2032.
-
North America Neuropathic Pain Market to 2032, By Procedure
- Non-Invasive is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 2,412.23 USD Billion in the year 2024.
- Non-Invasive is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 14.84 % in forecast period 2025-2032.
-
North America Neuropathic Pain Market to 2032, By Technology
- Transcutaneous Electrical Nerve Stimulation is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 1,964.05 USD Billion in the year 2024.
- Transcutaneous Electrical Nerve Stimulation is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 14.90 % in forecast period 2025-2032.
-
North America Neuropathic Pain Market to 2032, By Modality
- Portable is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 2,189.45 USD Billion in the year 2024.
- Stationary is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 14.37 % in forecast period 2025-2032.
-
North America Neuropathic Pain Market to 2032, By Mode of Purchase
- Prescription-Based Devices is the largest segment in North America Neuropathic Pain Market to 2032 with a revenue of 2,555.08 USD Billion in the year 2024.
- Prescription-Based Devices is the Fastest growing segment in North America Neuropathic Pain Market to 2032 with a Growth rate of 14.85 % in forecast period 2025-2032.
North America Neuropathic Pain Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Omron Healthcare, Inc. | |||
| NEVRO CORP. | |||
| Integer Holdings Corporation | |||
| Boston Scientific Corporation or its affiliates | |||
North America Neuropathic Pain Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Neuropathic Pain Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Neuropathic Pain Market is segmented based on Segmentation End User,Distribution Channel,Pain Type,Indication,Type,Product Type,Procedure,Technology,Modality,Mode of Purchase.
North America Neuropathic Pain Market was valued at USD 3,359.53(Revenue in USD Billion) in 2020.
North America Neuropathic Pain Market is projected to grow at a CAGR of 14.56% during the forecast period of 2024 to 2032.
The Prescription-Based Devices segment is expected to dominate the North America Neuropathic Pain Market, holding a largest market share of 2,555.08 USD Billion in 2024
North America Neuropathic Pain Market Scope
North America Neuropathic Pain Market Segmentation & Scope
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Frequently Asked Questions
The North America Neuropathic Pain Market is segmented based on Segmentation End User,Distribution Channel,Pain Type,Indication,Type,Product Type,Procedure,Technology,Modality,Mode of Purchase.
North America Neuropathic Pain Market was valued at USD 3,359.53(Revenue in USD Billion) in 2020.
North America Neuropathic Pain Market is projected to grow at a CAGR of 14.56% during the forecast period of 2024 to 2032.
The estimated market value of the North America Neuropathic Pain Market for final year is USD 6,828.36 (USD Billion).
North America Neuropathic Pain Market Company Profiling
Frequently Asked Questions
The North America Neuropathic Pain Market is segmented based on Segmentation End User,Distribution Channel,Pain Type,Indication,Type,Product Type,Procedure,Technology,Modality,Mode of Purchase.
North America Neuropathic Pain Market was valued at USD 3,359.53(Revenue in USD Billion) in 2020.
North America Neuropathic Pain Market is projected to grow at a CAGR of 14.56% during the forecast period of 2024 to 2032.
The estimated market value of the North America Neuropathic Pain Market for final year is USD 6,828.36 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.